IBDEI2TL ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47341,1,4,0)
 ;;=4^C82.27
 ;;^UTILITY(U,$J,358.3,47341,2)
 ;;=^5001488
 ;;^UTILITY(U,$J,358.3,47342,0)
 ;;=C82.28^^209^2346^167
 ;;^UTILITY(U,$J,358.3,47342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47342,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47342,1,4,0)
 ;;=4^C82.28
 ;;^UTILITY(U,$J,358.3,47342,2)
 ;;=^5001489
 ;;^UTILITY(U,$J,358.3,47343,0)
 ;;=C82.29^^209^2346^161
 ;;^UTILITY(U,$J,358.3,47343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47343,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47343,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,47343,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,47344,0)
 ;;=C82.30^^209^2346^179
 ;;^UTILITY(U,$J,358.3,47344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47344,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,47344,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,47344,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,47345,0)
 ;;=C82.31^^209^2346^172
 ;;^UTILITY(U,$J,358.3,47345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47345,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47345,1,4,0)
 ;;=4^C82.31
 ;;^UTILITY(U,$J,358.3,47345,2)
 ;;=^5001492
 ;;^UTILITY(U,$J,358.3,47346,0)
 ;;=C82.32^^209^2346^176
 ;;^UTILITY(U,$J,358.3,47346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47346,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47346,1,4,0)
 ;;=4^C82.32
 ;;^UTILITY(U,$J,358.3,47346,2)
 ;;=^5001493
 ;;^UTILITY(U,$J,358.3,47347,0)
 ;;=C82.33^^209^2346^174
 ;;^UTILITY(U,$J,358.3,47347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47347,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47347,1,4,0)
 ;;=4^C82.33
 ;;^UTILITY(U,$J,358.3,47347,2)
 ;;=^5001494
 ;;^UTILITY(U,$J,358.3,47348,0)
 ;;=C82.34^^209^2346^170
 ;;^UTILITY(U,$J,358.3,47348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47348,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47348,1,4,0)
 ;;=4^C82.34
 ;;^UTILITY(U,$J,358.3,47348,2)
 ;;=^5001495
 ;;^UTILITY(U,$J,358.3,47349,0)
 ;;=C82.35^^209^2346^173
 ;;^UTILITY(U,$J,358.3,47349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47349,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47349,1,4,0)
 ;;=4^C82.35
 ;;^UTILITY(U,$J,358.3,47349,2)
 ;;=^5001496
 ;;^UTILITY(U,$J,358.3,47350,0)
 ;;=C82.36^^209^2346^175
 ;;^UTILITY(U,$J,358.3,47350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47350,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47350,1,4,0)
 ;;=4^C82.36
 ;;^UTILITY(U,$J,358.3,47350,2)
 ;;=^5001497
 ;;^UTILITY(U,$J,358.3,47351,0)
 ;;=C82.37^^209^2346^178
 ;;^UTILITY(U,$J,358.3,47351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47351,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Spleen
 ;;^UTILITY(U,$J,358.3,47351,1,4,0)
 ;;=4^C82.37
 ;;^UTILITY(U,$J,358.3,47351,2)
 ;;=^5001498
 ;;^UTILITY(U,$J,358.3,47352,0)
 ;;=C82.38^^209^2346^177
 ;;^UTILITY(U,$J,358.3,47352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47352,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47352,1,4,0)
 ;;=4^C82.38
 ;;^UTILITY(U,$J,358.3,47352,2)
 ;;=^5001499
 ;;^UTILITY(U,$J,358.3,47353,0)
 ;;=C82.39^^209^2346^171
 ;;^UTILITY(U,$J,358.3,47353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47353,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47353,1,4,0)
 ;;=4^C82.39
